|Molar Mass||129.247 g·mol−1|
DMHA Powder is an advanced research product meticulously designed for scientific investigations in various fields, including pharmacology and physiology. This liquid formulation contains DMHA (2-aminoisoheptane), a compound that has gained interest for its potential effects on physiological parameters. It is imperative to underscore that this product is exclusively intended for research purposes and should not be considered for human consumption.
DMHA Powder is distinguished by its solubility and purity. The powder formulation allows for precise dosing, while stringent quality control measures ensure its reliability in research applications.
Researchers and scientists can employ DMHA Powder for a range of research areas, including studies on nasal congestion, hypotension, and pain thresholds. The powder form offers flexibility in dosing and application, making it a valuable tool for investigating DMHA’s potential in these domains.
DMHA has been explored for its potential in alleviating nasal congestion and promoting respiratory relief. Research studies have investigated its impact on nasal passages, and researchers can further explore its effects on respiratory function.
Some preliminary research suggests that DMHA may have hypotensive effects, which could influence blood pressure regulation. Researchers can investigate its impact on blood pressure and its potential mechanisms in preclinical models.
DMHA has also been studied for its potential impact on pain thresholds. Researchers can explore its effects on pain perception and threshold levels, contributing to our understanding of its analgesic properties.
DMHA Powder is a research product meticulously designed for scientific investigations in pharmacology and physiology. With its solubility and purity, it offers a versatile option for a wide range of research applications. Researchers can explore the potential benefits of DMHA in alleviating nasal congestion, influencing blood pressure regulation, and modulating pain thresholds with the support of existing scientific literature.
- CHARLIER R, PHILIPPOT E. Activité pneumodilatatrice comparée, chez l’homme de trois amines aliphatiques en aérosols [Comparison of the bronchodilatory action in man of three aliphatic amines in aerosol]. Arch Int Pharmacodyn Ther. 1950 Apr 15;82(2):243-6. Undetermined Language. PMID: 15414026. [Read More]
- FELLOWS EJ. The pharmacology of 2-amino-6-methylheptane. J Pharmacol Exp Ther. 1947 Aug;90(4):351-8. PMID: 20265812. [Read More]